Evidence map›Paper›PMID 39614273›Full record

ArticleBMC pulmonary medicine2024

Predicting solitary pulmonary lesions in breast cancer patients using

Yangyang Xue, Weishu Hou, Yanhui He, Alei Xu, Xiaohu Li

Abstract read
In one paragraph

Article in BMC pulmonary medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yangyang XueDepartment of Nuclear Medicine, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, 230022, China.
Weishu HouDepartment of Radiology, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, 230022, China.
Yanhui HeDepartment of Nuclear Medicine, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, 230022, China.
Alei XuDepartment of Nuclear Medicine, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, 230022, China.
Xiaohu LiDepartment of Radiology, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, 230022, China. AYFYlixiaohu@163.com.

Funding

Research Fund of Anhui Institute of translational medicine (CN) 2022zhyx-B14Research Project of Anhui Province (CN) 2021xkj134
6 · The paper itself

Abstract

backgroundSolitary pulmonary nodules (SPNs) remain difficult to diagnose for clinical therapeutic purposes in patients with a history of breast cancer. This study try to investigate the value of

methodsOne hundred and twenty breast cancer patients with newly detected SPNs were enrolled in the study and divided into a primary lung cancer (PLC) group and a breast cancer metastasis (BCM) group. The clinicopathological characteristics as well as metabolic and morphological characteristics on

resultsClinicopathological terms of carcinoembryonic antigen (CEA) and CA15-3 levels exhibited significant differences between PLC and BCM groups (P = 0.005 and P = 0.001, respectively). Metabolic characteristics of

conclusions

Indexed as

Breast NeoplasmsFluorodeoxyglucose F18Lung NeoplasmsPositron Emission Tomography Computed TomographyRadiopharmaceuticalsSolitary Pulmonary NoduleAdultAgedCarcinoembryonic AntigenDiagnosis, DifferentialFemaleHumansLymphatic MetastasisMiddle AgedMucin-1Multivariate AnalysisCarcinoembryonic AntigenFluorodeoxyglucose F18Mucin-1Radiopharmaceuticals18F-FDG-PET/CTBreast cancerMetastasisPrimary lung cancerSolitary pulmonary nodule

Identifiers

PMID39614273
PMCPMC11607836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.